Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!

Emmanuel Deshayes, Ioannis Karfis, Lore Santoro, Magdalena Mileva, Rachele Danieli, Kévin Hebert, Marco Maccauro, Carlo Chiesa and Manuel Bardiès
Journal of Nuclear Medicine April 2025, jnumed.124.268880; DOI: https://doi.org/10.2967/jnumed.124.268880
Emmanuel Deshayes
1Institut du Cancer de Montpellier, Montpellier, France;
2Université de Montpellier, Montpellier, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis Karfis
3Institut Jules Bordet, Brussels, Belgium; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lore Santoro
1Institut du Cancer de Montpellier, Montpellier, France;
2Université de Montpellier, Montpellier, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Mileva
3Institut Jules Bordet, Brussels, Belgium; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachele Danieli
3Institut Jules Bordet, Brussels, Belgium; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kévin Hebert
1Institut du Cancer de Montpellier, Montpellier, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Maccauro
4Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo Chiesa
4Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Bardiès
1Institut du Cancer de Montpellier, Montpellier, France;
2Université de Montpellier, Montpellier, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.124.268880
DOI 
https://doi.org/10.2967/jnumed.124.268880
PubMed 
40210422

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication November 24, 2024
  • Accepted for publication December 5, 2024
  • Published online April 10, 2025.

Copyright & Usage 
© 2025 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: April 2025 to April 2025

AbstractFullPdf
Apr 2025014064
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
Emmanuel Deshayes, Ioannis Karfis, Lore Santoro, Magdalena Mileva, Rachele Danieli, Kévin Hebert, Marco Maccauro, Carlo Chiesa, Manuel Bardiès
Journal of Nuclear Medicine Apr 2025, jnumed.124.268880; DOI: 10.2967/jnumed.124.268880

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
Emmanuel Deshayes, Ioannis Karfis, Lore Santoro, Magdalena Mileva, Rachele Danieli, Kévin Hebert, Marco Maccauro, Carlo Chiesa, Manuel Bardiès
Journal of Nuclear Medicine Apr 2025, jnumed.124.268880; DOI: 10.2967/jnumed.124.268880
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Determining PSMA-617 Mass and Molar Activity in Pluvicto Doses
  • The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire